Literature DB >> 16789642

Childhood sporadic pheochromocytoma: clinical profile and outcome in 19 patients.

A Bhansali1, R Rajput, A Behra, K L N Rao, N Khandelwal, B D Radotra.   

Abstract

Sporadic pheochromocytoma is a rare tumor of childhood and accounts for less than 1% of cases of hypertension. We describe the presentation and outcome of 19 adolescents with sporadic pheochromocytoma seen over past 10 years at a tertiary care center in north India. The mean age (+/- SD) at presentation was 15.1 +/- 2.4 years with range from 9-18 years. The male to female ratio was 12:7. The lag time between onset of symptoms to diagnosis ranged from 1 month to 5 years with mean (+/- SD) of 1.09 +/- 1.02 years. The majority of children presented with hypertension and paroxysms. Paroxysms, characterized by the triad of headache, palpitations and sweating, was present in 13 (68%) of these patients. Twelve (63%) patients had postural fall in blood pressure, ten (53%) had abdominal pain, four (21%) had visual blurring, and three (16%) each had palpable abdominal mass and significant weight loss at presentation. Nausea and vomiting are common symptoms in children with pheochromocytoma and were present in six (32%) and three (16%) patients, respectively. Café-au-lait macule was present in only two (11%) patients. Urinary vanilyl mandelic acid (VMA) was found to be significantly high in ten (53%) patients, and urinary epinephrine and norepinephrine in eight (42%). Six (32%) patients had both VMA and urinary epinephrine and norepinephrine within normal limits and five (26%) had significant elevation of both. The tumor was localized by ultrasonography in 17 (89%) patients and by computed tomography in 18 (95%), and in one patient it was localized by 131I-MIBG scan. Sixteen (84%) patients had adrenal pheochromocytoma (including four with bilateral masses), while the remaining three (16%) had abdominal extra-adrenal pheochromocytoma originating from sympathetic ganglions. The mean (+/- SD) diameter of the tumor was 4.4 +/- 1.7 cm, ranging from 2.2-7.5 cm. Pre-operatively, hypertension was managed by phenoxybenzamine in six (32%), sustained release prazosin in 12 (63%), beta-blockers in 14 (74%), calcium channel blockers in 12 (63%), and angiotensin converting enzyme inhibitors and diuretics in only two (11%) patients. Eighteen (85%) patients underwent exploratory laparotomy for removal of the tumor. On follow-up, 13 (72%) patients became normotensive, while six (32%) patients continued to have hypertension. In conclusion, childhood pheochromocytoma is characterized by atypical symptomatology; ultrasonography is a useful modality in localizing the lesions in the majority of patients; surgery is rewarding in most patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16789642     DOI: 10.1515/jpem.2006.19.5.749

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

1.  Cerebral ischaemic stroke and bilateral pheochromocytoma.

Authors:  Sana Abourazzak; Samir Atmani; Larbi El Arqam; Sanae Chaouki; Smail Labib; Moustapha Harrandou; Siham Tizniti; Youssef Bouabdellah; Abdelhak Bouharrou; Moustapha Hida
Journal:  BMJ Case Rep       Date:  2010-05-11

2.  Extra-adrenal Pheochromocytoma in an Adolescent.

Authors:  Ibrahim Abdullah; Kori Cossey; Rebecca K Jeanmonod
Journal:  West J Emerg Med       Date:  2011-05

Review 3.  Renal and adrenal tumours in children.

Authors:  Kieran McHugh
Journal:  Cancer Imaging       Date:  2007-03-05       Impact factor: 3.909

4.  Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE).

Authors:  Marie de Tersant; Lucile Généré; Claire Freyçon; Sophie Villebasse; Rachid Abbas; Anne Barlier; Damien Bodet; Nadège Corradini; Anne-Sophie Defachelles; Natacha Entz-Werle; Cyrielle Fouquet; Louise Galmiche; Virginie Gandemer; Brigitte Lacour; Ludovic Mansuy; Daniel Orbach; Claire Pluchart; Yves Réguerre; Charlotte Rigaud; Sabine Sarnacki; Nicolas Sirvent; Jean-Louis Stephan; Estelle Thebaud; Anne-Paule Gimenez-Roqueplo; Laurence Brugières
Journal:  J Endocr Soc       Date:  2020-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.